BUNKER KEVIN D. (Chief Operating Officer) sold 4.2% of their position (10K shares) of ZENTALIS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $781.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/12/2021ACC: 0001725160-21-000222
Officer· Chief Operating Officer
Since Apr 2020
-10K
Net shares
Net seller
$781.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
240K acquired · 250K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−240K
Price / share
—
Trade value
—
% of position
24.1%
11/9/2021
995.07K→755.07K
Common Stock
Indirect
Shares
+240K
Price / share
—
Trade value
—
% of position
New position
11/9/2021
0.00→240K
Common Stock
Indirect
Shares
−10K
Price / share
$78.15
Trade value
$781.47K
% of position
4.2%
11/10/2021
240K→230K
Total
Net shares
−10K
Net value
-$781.47K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/9/2021 | G · Gift | −240K | — | — | 24.1% | 995.07K | 755.07K |
| Common Stock Indirect | 11/9/2021 | G · Gift | +240K | — | — | New position | 0.00 | 240K |
| Common Stock Indirect | 11/10/2021 | S · Sale | −10K | $78.15 | $781.47K | 4.2% | 240K | 230K |
| Total | −10K | -$781.47K | ||||||
Derivative Transactions0
No derivative transactions reported